Filing Details
- Accession Number:
- 0001484612-25-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-16 17:24:11
- Reporting Period:
- 2025-05-15
- Filing Date:
- 2025-05-16
- Accepted Time:
- 2025-05-16 17:24:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1484612 | Outset Medical Inc. | OM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1304125 | Leslie Trigg | 3052 Orchard Drive San Jose CA 95134 | Chair And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-15 | 935 | $17.80 | 58,129 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 41,666 | Indirect | Trigg 2002 Rev Trust |
Common Stock | 584 | Indirect | Trigg Family Trust |
Footnotes
- Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,770 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Includes 333 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2024 to February 28, 2025. This transaction is exempt from Rule 16b-3(c).